Working… Menu
Trial record 60 of 1013 for:    BMD

A Phase I/II Study of BMN053 in Subjects With Duchenne Muscular Dystrophy (DMD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01957059
Recruitment Status : Terminated
First Posted : October 8, 2013
Last Update Posted : December 8, 2017
Information provided by (Responsible Party):
BioMarin Pharmaceutical

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : August 3, 2016
Actual Study Completion Date : August 3, 2016